<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="cns13716" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">CNS Neurosci Ther</journal-id>
      <journal-id journal-id-type="iso-abbrev">CNS Neurosci Ther</journal-id>
      <journal-id journal-id-type="doi">10.1111/(ISSN)1755-5949</journal-id>
      <journal-id journal-id-type="publisher-id">CNS</journal-id>
      <journal-title-group>
        <journal-title>CNS Neuroscience &amp; Therapeutics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1755-5930</issn>
      <issn pub-type="epub">1755-5949</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34387022</article-id>
      <article-id pub-id-type="pmc">8504518</article-id>
      <article-id pub-id-type="doi">10.1111/cns.13716</article-id>
      <article-id pub-id-type="publisher-id">CNS13716</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Original Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>APOE genotype moderates the relationship between LRP1 polymorphism and cognition across the Alzheimer's disease spectrum via disturbing default mode network</article-title>
        <alt-title alt-title-type="left-running-head">ZANG et al.</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="cns13716-cr-0001" contrib-type="author">
          <name>
            <surname>Zang</surname>
            <given-names>Feifei</given-names>
          </name>
          <xref rid="cns13716-aff-0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="cns13716-cr-0002" contrib-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Yao</given-names>
          </name>
          <xref rid="cns13716-aff-0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="cns13716-cr-0003" contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Qianqian</given-names>
          </name>
          <xref rid="cns13716-aff-0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="cns13716-cr-0004" contrib-type="author">
          <name>
            <surname>Tan</surname>
            <given-names>Chang</given-names>
          </name>
          <xref rid="cns13716-aff-0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="cns13716-cr-0005" contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Qing</given-names>
          </name>
          <xref rid="cns13716-aff-0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="cns13716-cr-0006" contrib-type="author" corresp="yes">
          <name>
            <surname>Xie</surname>
            <given-names>Chunming</given-names>
          </name>
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5978-9689</contrib-id>
          <xref rid="cns13716-aff-0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="cns13716-aff-0002" ref-type="aff">
<sup>2</sup>
</xref>
          <address>
            <email>chmxie@163.com</email>
          </address>
        </contrib>
        <contrib id="cns13716-cr-0007" contrib-type="author">
          <collab collab-type="authors">Alzheimer’s Disease Neuroimaging Initiative*</collab>
        </contrib>
      </contrib-group>
      <aff id="cns13716-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<named-content content-type="organisation-division">Affiliated ZhongDa Hospital</named-content>
<named-content content-type="organisation-division">School of Medicine</named-content>
<institution>Southeast University</institution>
<city>Nanjing</city>
<country country="CN">China</country>
</aff>
      <aff id="cns13716-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Neuropsychiatric Institute</named-content>
<named-content content-type="organisation-division">Affiliated ZhongDa Hospital</named-content>
<institution>Southeast University</institution>
<city>Nanjing</city>
<country country="CN">China</country>
</aff>
      <author-notes>
        <corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>
Chunming Xie, Department of Neurology, Affiliated Zhongda Hospital, School of Medicine, Southeast University, No.87 Dingjiaqiao Road, Nanjing, Jiangsu 210009, China.<break/>
Email: <email>chmxie@163.com</email>
<break/>
</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>8</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <volume>27</volume>
      <issue seq="130">11</issue>
      <issue-id pub-id-type="doi">10.1002/cns.v27.11</issue-id>
      <fpage>1385</fpage>
      <lpage>1395</lpage>
      <history>
<date date-type="rev-recd"><day>31</day><month>7</month><year>2021</year></date>
<date date-type="received"><day>06</day><month>5</month><year>2021</year></date>
<date date-type="accepted"><day>03</day><month>8</month><year>2021</year></date>
</history>
      <permissions>
        <!--Copyright &#x000a9; 2021 John Wiley & Sons Ltd-->
        <copyright-statement content-type="article-copyright">© 2021 The Authors. <italic toggle="yes">CNS Neuroscience &amp; Therapeutics</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="file:CNS-27-1385.pdf"/>
      <abstract id="cns13716-abs-0001">
        <title>Abstract</title>
        <sec id="cns13716-sec-0001">
          <title>Aims</title>
          <p>This study aims to investigate the mechanisms by which apolipoprotein E (<italic toggle="yes">APOE</italic>) genotype modulates the relationship between low‐density lipoprotein receptor‐related protein 1 (<italic toggle="yes">LRP1</italic>) rs1799986 variant on the default mode network (DMN) and cognition in Alzheimer's disease (AD) spectrum populations.</p>
        </sec>
        <sec id="cns13716-sec-0002">
          <title>Methods</title>
          <p>Cross‐sectional 168 subjects of AD spectrum were obtained from Alzheimer's Disease Neuroimaging Initiative database with resting‐state fMRI scans and neuropsychological scores data. Multivariable linear regression analysis was adopted to investigate the main effects and interaction of <italic toggle="yes">LRP1</italic> and disease on the DMN. Moderation and interactive analyses were performed to assess the relationships among <italic toggle="yes">APOE</italic>, <italic toggle="yes">LRP1</italic>, and cognition. A support vector machine model was used to classify AD spectrum with altered connectivity as an objective diagnostic biomarker.</p>
        </sec>
        <sec id="cns13716-sec-0003">
          <title>Results</title>
          <p>The main effects and interaction of <italic toggle="yes">LRP1</italic> and disease were mainly focused on the core hubs of frontal‐parietal network. Several brain regions with altered connectivity were correlated with cognitive scores in <italic toggle="yes">LRP1</italic>‐T carriers, but not in non‐carriers. <italic toggle="yes">APOE</italic> regulated the effect of <italic toggle="yes">LRP1</italic> on cognitive performance. The functional connectivity of numerous brain regions within <italic toggle="yes">LRP1</italic>‐T carriers yielded strong power for classifying AD spectrum.</p>
        </sec>
        <sec id="cns13716-sec-0004">
          <title>Conclusion</title>
          <p>These findings suggested <italic toggle="yes">LRP1</italic> could affect DMN and provided a stage‐dependent neuroimaging biomarker for classifying AD spectrum populations.</p>
        </sec>
      </abstract>
      <abstract abstract-type="graphical" id="cns13716-abs-0002">
        <p>The main effects and interaction of <italic toggle="yes">LRP1</italic> genotype and disease status focused on the core hubs of frontal‐parietal network across the Alzheimer's disease spectrum. <italic toggle="yes">APOE</italic> genotype regulated the effect of <italic toggle="yes">LRP1</italic> genotype on cognitive performance.<boxed-text position="anchor" content-type="graphic" id="cns13716-blkfxd-0001"><graphic xlink:href="CNS-27-1385-g001.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p>
      </abstract>
      <kwd-group>
        <kwd id="cns13716-kwd-0001">Alzheimer's disease</kwd>
        <kwd id="cns13716-kwd-0002">apolipoprotein E</kwd>
        <kwd id="cns13716-kwd-0003">default mode network</kwd>
        <kwd id="cns13716-kwd-0004">low‐density lipoprotein receptor‐related protein 1</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="funding-0001">
          <funding-source>Key Projects of Jiangsu Commission of Health</funding-source>
          <award-id>ZDB2020008</award-id>
        </award-group>
        <award-group id="funding-0002">
          <funding-source>
            <institution-wrap>
              <institution>National Natural Science Foundation of China
</institution>
              <institution-id institution-id-type="doi">10.13039/501100001809</institution-id>
            </institution-wrap>
          </funding-source>
          <award-id>81671256</award-id>
          <award-id>81871069</award-id>
          <award-id>82071204</award-id>
        </award-group>
        <award-group id="funding-0003">
          <funding-source>Key Project for Research and Development Program of Jiangsu Province</funding-source>
          <award-id>BE2018741</award-id>
        </award-group>
        <award-group id="funding-0004">
          <funding-source>Nanjing International Joint Research and Development Project</funding-source>
          <award-id>201715013</award-id>
        </award-group>
        <award-group id="funding-0005">
          <funding-source>National Key Projects for Research and Development Program of China</funding-source>
          <award-id>2016YFC1305800</award-id>
          <award-id>2016YFC1305802</award-id>
        </award-group>
        <award-group id="funding-0006">
          <funding-source>Postgraduate Research &amp; Practice Innovation Program of Jiangsu Province</funding-source>
          <award-id>KYCX19_0115</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="5"/>
        <table-count count="1"/>
        <page-count count="11"/>
        <word-count count="7377"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>November 2021</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.8 mode:remove_FC converted:11.10.2021</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <p content-type="self-citation">
<mixed-citation publication-type="journal" id="cns13716-cit-1001">
<string-name>
<surname>Zang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>C</given-names>
</string-name>; <collab collab-type="authors">Alzheimer’s Disease Neuroimaging Initiative</collab>
. <article-title>APOE genotype moderates the relationship between LRP1 polymorphism and cognition across the Alzheimer's disease spectrum via disturbing default mode network</article-title>. <source>CNS Neurosci Ther</source>. <year>2021</year>;<volume>27</volume>:<fpage>1385</fpage>–<lpage>1395</lpage>. <pub-id pub-id-type="doi">10.1111/cns.13716</pub-id>
</mixed-citation>
</p>
      <fn-group id="cns13716-ntgp-0001">
        <fn id="cns13716-note-0001">
          <label>*</label>
          <p>The data used in preparation of this article were obtained from the Alzheimer’s disease Neuroimaging Initiative (ADNI) database (http://www.loni.ucla.edu/). Investigators within the ADNI database contributed to the design and implementation of the ADNI and provided data but did not participate in the analysis or write this report. For a complete listing of ADNI investigators, please see http://adni.loni.usc.edu/wp‐content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf</p>
        </fn>
        <fn fn-type="funding" id="cns13716-note-0002">
          <p>
<bold>Funding information</bold>
</p>
          <p>This study was granted funding by the National Key Projects for Research and Development Program of China (2016YFC1305800, 2016YFC1305802, CMX), the National Natural Science Foundation of China (81671256, 81871069, 82071204, CMX), the Key Project for Research and Development Program of Jiangsu Province (BE2018741, CMX), the Key Projects of Jiangsu Commission of Health (ZDB2020008, CMX), the Nanjing International Joint Research and Development Project (201715013), and the Postgraduate Research &amp; Practice Innovation Program of Jiangsu Province (KYCX19_0115).</p>
        </fn>
      </fn-group>
    </notes>
  </front>
  <body id="cns13716-body-0001">
    <sec id="cns13716-sec-0005">
      <label>1</label>
      <title>INTRODUCTION</title>
      <p>Low‐density lipoprotein receptor‐related protein 1 (LRP1) is a large cell surface transmembrane receptor, highly expressed in the neurons, astrocytes, and vasculatures of the brain. It regulates the pathogenesis of Alzheimer's disease (AD).<xref rid="cns13716-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Reportedly, up to 50 structurally diverse proteins including β‐amyloid (Aβ) and apolipoprotein E (APOE) are ligands of LRP1.<xref rid="cns13716-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Notably, LRP1 promotes Aβ clearance, maintains synaptic integrity, and regulates lipid metabolism in the brain.<xref rid="cns13716-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="cns13716-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>
<italic toggle="yes">LRP1</italic> gene rs1799986 polymorphism in exon 3 has a silent mutation of C allele to T allele and generates three isoform genotypes including CC, TC, and TT. The T allele potentially confers a risk factor for developing sporadic AD. Nonetheless, the relationship of this variant with AD is elusive. Several previous studies reported that <italic toggle="yes">LRP1</italic> rs1799986 polymorphism was connected with late‐onset AD.<xref rid="cns13716-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="cns13716-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="cns13716-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="cns13716-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> However, recent three genome‐wide association studies failed to discover a significant impact of this variant on AD risk.<xref rid="cns13716-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="cns13716-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="cns13716-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>
</p>
      <p>Despite the conflicting findings in polymorphism, one human postmortem study with brain tissues revealed that LRP1 levels from the middle frontal cortex were significantly reduced in AD patients compared with healthy controls. Also, LRP1 levels progressively decreased with the increasing age in controls, whereas a higher level of LRP1 correlated with later age of AD onset.<xref rid="cns13716-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> Elsewhere, another postmortem study found significantly decreased LRP1 levels in the hippocampus of mild cognitive impairment (MCI), an early stage of AD, compared with age‐matched controls.<xref rid="cns13716-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> These observations preliminarily suggest that the disrupted LRP1 levels might partly reflect brain function.</p>
      <p>Accumulating evidence from animal studies indicates that LRP1 has been implicated in the process of Aβ and Tau pathology and related to cognitive function. Besides, LRP1 potentially acts predominantly over Aβ clearance in a mouse model of AD.<xref rid="cns13716-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> In cerebral blood vessels, LRP1 importantly mediates the rapid removal of Aβ from the brain to transport across the blood‐brain barrier; also, endothelial LRP1 may be treated as a potential target for the treatment of AD.<xref rid="cns13716-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Additionally, recent research identified that knockdown <italic toggle="yes">LRP1</italic> significantly reduced tau uptake in neurons and tau propagation between neurons. This implies a master regulatory role of LRP1 in tau pathology, thereby providing a novel therapeutic target for tau‐related neurodegenerative diseases.<xref rid="cns13716-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Drug trials also have revealed that low‐dose pioglitazone ameliorates learning and memory impairment by upregulating LRP1 expression in the hippocampus.<xref rid="cns13716-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Moreover, APOE‐ε4 mediates Aβ pathology based on its neuronal receptor LRP1<xref rid="cns13716-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> and <italic toggle="yes">LRP1</italic> knockout prevents the increase of Aβ pathology caused by <italic toggle="yes">APOE</italic>‐ε4 expression.<xref rid="cns13716-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Therefore, LRP1 is a common factor modulating Aβ and tau metabolism to maintain brain homeostasis.</p>
      <p>Default mode network (DMN) is an intrinsic brain networks that most consistently exists in healthy and disease populations; its deterioration acts as a tracking tool to monitor AD progression.<xref rid="cns13716-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="cns13716-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> Aβ accumulation preferentially commences in several core regions of DMN, including the precuneus, medial orbitofrontal, and posterior cingulate cortex, and further affected brain connectivity within DMN.<xref rid="cns13716-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Nevertheless, information on how the <italic toggle="yes">LRP1</italic> gene polymorphism affects DMN in the AD spectrum is scant, despite being the regulatory effect of LRP1 on Aβ. Additionally, considering that APOE exacerbates Aβ pathology in an LRP1‐dependent manner,<xref rid="cns13716-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> investigating the role of <italic toggle="yes">APOE</italic> on the relationship between <italic toggle="yes">LRP1</italic> and cognition in AD spectrum is of importance.</p>
      <p>Herein, we first assessed whether the <italic toggle="yes">LRP1</italic> genotype disturbed functional connectivity (FC) within DMN and affected cognitive performance across all subjects. Secondly, this work explored the relationships among <italic toggle="yes">APOE</italic>, <italic toggle="yes">LRP1</italic>, and cognition in the AD spectrum with moderation analysis. Thirdly, a support vector machine (SVM) model was employed to classify AD spectrum with the altered connectivity within DMN as an objective diagnostic biomarker, based on <italic toggle="yes">LRP1</italic> genotypes.</p>
    </sec>
    <sec sec-type="methods" id="cns13716-sec-0006">
      <label>2</label>
      <title>METHODS</title>
      <sec id="cns13716-sec-0007">
        <label>2.1</label>
        <title>Participants</title>
        <p>Cross‐sectional data were downloaded from the Alzheimer's disease Neuroimaging Initiative (ADNI) database (<ext-link xlink:href="http://adni.loni.usc.edu" ext-link-type="uri">http://adni.loni.usc.edu</ext-link>) before March 21, 2021. Moreover, resting‐state functional magnetic resonance imaging (rs‐fMRI) images were downloaded from ADNI‐1, ADNI‐GO, ADNI‐2, and ADNI‐3 projects. If two or more rs‐fMRI scans were performed at baseline, the first available scan was included for analysis (<italic toggle="yes">n</italic> = 184). Corrupted image sequences (<italic toggle="yes">n</italic> = 6), image quality control failure (<italic toggle="yes">n</italic> = 4), and excessive head motion (<italic toggle="yes">n</italic> = 6) were excluded. In total, 168 participants including 55 CN, 45 subjective cognitive decline (SCD), 42 MCI, and 26 mild AD participants were enrolled for the final analysis. Mini‐Mental State Examination (MMSE) was adopted as a measure of general cognition since it was available across all participants.<xref rid="cns13716-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> In addition, demographic and genetic information were obtained from the ADNI database. Genetic genotyping for <italic toggle="yes">APOE</italic> and <italic toggle="yes">LRP1</italic> was performed as previously described.<xref rid="cns13716-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Participants with at least one ε4 allele were categorized into <italic toggle="yes">APOE</italic>‐ε4 carriers (<italic toggle="yes">APOE</italic> ε4<sup>+</sup>), while others without ε4 alleles were categorized into <italic toggle="yes">APOE</italic>‐ε4 non‐carriers (<italic toggle="yes">APOE</italic> ε4<sup>−</sup>). Similarly, those with at least one T allele were categorized into <italic toggle="yes">LRP1</italic>‐T carriers (<italic toggle="yes">LRP1</italic> T<sup>+</sup>), while others without T allele were categorized into <italic toggle="yes">LRP1</italic>‐T non‐carriers (<italic toggle="yes">LRP1</italic> T<sup>−</sup>). Hardy‐Weinberg equilibrium (HWE) test for each gene was calculated. Flow chart was shown in Figure <xref rid="cns13716-sup-0001" ref-type="supplementary-material">S1</xref>.</p>
      </sec>
      <sec id="cns13716-sec-0008">
        <label>2.2</label>
        <title>Statistics analyses</title>
        <sec id="cns13716-sec-0009">
          <label>2.2.1</label>
          <title>Demographic and neuropsychological data analysis</title>
          <p>First, the Shapiro‐Wilk test was adopted to assess the data normality of continuous variables. A non‐parametric test was analyzed when data distributions were not normal. Levene's test was examined to assess the homogeneity of variance. One‐way analysis of variance (ANOVA) was separately used to compare the group differences of age, years of education, and MMSE scores. Non‐parametric Kruskal‐Wallis test was used if the Shapiro‐Wilk test or Levene's test <italic toggle="yes">p</italic> &lt; 0.05. Chi‐square tests were applied to compare the group differences of gender, <italic toggle="yes">APOE</italic>‐ε4 status and <italic toggle="yes">LRP1</italic>‐T status. The significant level was set at <italic toggle="yes">p </italic>&lt; 0.05. Post hoc analyses with Bonferroni correction (<italic toggle="yes">p </italic>&lt; 0.05/6 = 0.0084) were essential in establishing the significance between any two groups. All statistical analyses were performed using SPSS 22.0 software (SPSS, Inc., Chicago, IL, USA).</p>
        </sec>
        <sec id="cns13716-sec-0010">
          <label>2.2.2</label>
          <title>DMN functional connectivity analysis</title>
          <p>A voxel‐wise one‐sample t‐test was performed on the subject‐specific maps to achieve a t‐map (DMN pattern, FDR corrected, <italic toggle="yes">p </italic>&lt; 0.001), which was shown in Figure <xref rid="cns13716-sup-0001" ref-type="supplementary-material">S2</xref>. This pattern was converted to a binary map. Of note, voxels outside of gray matter would be excluded. Subsequently, an overlap mask was generated by combining the above binary map and gray matter mask to prevent any spurious effects from white matter and ventricles. After controlling nuisance variables of age, gender, education, and <italic toggle="yes">APOE</italic> genotype, multivariable linear regression analysis was employed to investigate the effects of <italic toggle="yes">LRP1</italic> genotype, disease status, and <italic toggle="yes">LRP1</italic> × disease interaction on the DMN within the above overlap mask (3dRegAna, AFNI).</p>
          <p>The cluster‐level threshold corrected for multiple comparisons was derived using Monte Carlo simulation of the random noise distribution in the data using the latest 3dClustSim program with the ‐acf function in AFNI [overlap DMN mask correction (39,543 voxels), voxel‐level <italic toggle="yes">p</italic> &lt; 0.01, cluster‐level α &lt; 0.05, κ &gt; 113 voxels, cluster size &gt;3051 mm<sup>3</sup>; <ext-link xlink:href="https://afni.nimh.nih.gov/pub/dist/doc/program_help/3dClustSim.html" ext-link-type="uri">https://afni.nimh.nih.gov/pub/dist/doc/program_help/3dClustSim.html</ext-link>]</p>
        </sec>
        <sec id="cns13716-sec-0011">
          <label>2.2.3</label>
          <title>Behavioral correlations</title>
          <p>After controlling covariate effects of age, gender, years of education and <italic toggle="yes">APOE</italic>‐ε4 status, linear regression analyses across all the subjects were performed. This was to investigate the correlation between behavior performance and averaged FC extracted from each region of interest identified by the main and interactive effect of <italic toggle="yes">LRP1</italic> genotype and disease status on DMN. Then, we separately analyzed the correlations of regional FC to behavior performance, specifically for <italic toggle="yes">LRP1</italic>‐T carriers and non‐carriers.</p>
        </sec>
        <sec id="cns13716-sec-0012">
          <label>2.2.4</label>
          <title>Moderation and interactive effect analysis</title>
          <p>A simple linear moderation effect model under PROCESS macro for SPSS (model 1)<xref rid="cns13716-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> was performed to address whether <italic toggle="yes">APOE</italic> genotype moderates the genotype effect of <italic toggle="yes">LRP1</italic> on MMSE; or whether <italic toggle="yes">LRP1</italic> genotype moderates the genotype of <italic toggle="yes">APOE</italic> on MMSE, controlling for age, gender, and education. This was geared toward exploring the potential relationship between <italic toggle="yes">LRP1</italic> and <italic toggle="yes">APOE</italic>. Herein, either of the dichotomous <italic toggle="yes">LRP1</italic> genotype (<italic toggle="yes">LRP1</italic> T<sup>+</sup> and T<sup>−</sup>) or <italic toggle="yes">APOE</italic> genotype (<italic toggle="yes">APOE</italic> ε4<sup>+</sup> and ε4<sup>−</sup>) represents the independent variable, while another one represents moderator. MMSE represents the dependent variable. If the effect of independent variable size or sign on dependent variable varies with moderator, the effect of the independent variable on dependent variable is considered to be moderated by the moderator.</p>
          <p>Secondly, analysis of covariance (ANCOVA), with <italic toggle="yes">LRP1</italic> genotype and <italic toggle="yes">APOE</italic> genotype, was used as dichotomous fixed factors, adjusting for potential confounding variables of age, gender and education, to illustrate the interactive effect of <italic toggle="yes">LRP1</italic> and <italic toggle="yes">APOE</italic> on MMSE across all subjects.</p>
        </sec>
        <sec id="cns13716-sec-0013">
          <label>2.2.5</label>
          <title>Neuroimaging biomarker of FC for classifying AD spectrum disease</title>
          <p>The extracted mean FC from each region of interest was considered a predictive variable to classify the AD spectrum among all subjects. Further, this regional FC was adopted to classify the AD spectrum in separate <italic toggle="yes">LRP1</italic>‐T carriers and non‐carriers. The receiver operating characteristic (ROC) curve was used to calculate the area under the curve (AUC) with the better predictive effect as AUC close to 1. To verify the accuracy of the classification, a leave‐one‐out cross‐validation method was used in the linear support vector machine (SVM) model implemented under MATLAB LIBSVM library<xref rid="cns13716-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> and repeated 10,000 times permutation tests for the limited sample size. Unless specifically emphasized, the statistical significance was set at <italic toggle="yes">p </italic>&lt; 0.05.</p>
        </sec>
      </sec>
    </sec>
    <sec sec-type="results" id="cns13716-sec-0014">
      <label>3</label>
      <title>RESULTS</title>
      <sec id="cns13716-sec-0015">
        <label>3.1</label>
        <title>Demographic characteristics</title>
        <p>No differences were observed in gender and education among all participants (all <italic toggle="yes">p</italic> values &gt; 0.05). A significant decreasing trend was noted in age along the disease process, and the main difference existed between the MCI or AD groups and the CN group. While acknowledging no significance in <italic toggle="yes">LRP1</italic>‐T status, a slight marginal differential trend was noted (<italic toggle="yes">p</italic> = 0.052). Regarding <italic toggle="yes">APOE</italic>‐ε4 status, a remarkable discrepancy was noted with a tendency that the proportion of ε4 allele increased as the disease progressed. Furthermore, the MCI and AD groups showed a more significant decrease in MMSE scores; however, the SCD subjects had higher MMSE scores than the CN group. No genotype frequency deviated from HWE (LRP1, χ<sup>2</sup> = 2.455, <italic toggle="yes">p</italic> = 0.117; APOE, χ<sup>2</sup> = 1.580, <italic toggle="yes">p</italic> = 0.209). The characteristics of participants are summarized in Table <xref rid="cns13716-tbl-0001" ref-type="table">1</xref>.</p>
        <table-wrap position="float" id="cns13716-tbl-0001" content-type="TABLE">
          <label>TABLE 1</label>
          <caption>
            <p>Demographic, genetic and clinical data across all groups</p>
          </caption>
          <table frame="hsides" rules="groups">
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <thead valign="top">
              <tr style="border-bottom:solid 1px #000000">
                <th align="left" valign="top" rowspan="1" colspan="1">Items</th>
                <th align="left" valign="top" rowspan="1" colspan="1">CN (<italic toggle="yes">n</italic> = 55)</th>
                <th align="left" valign="top" rowspan="1" colspan="1">SCD (<italic toggle="yes">n</italic> = 45)</th>
                <th align="left" valign="top" rowspan="1" colspan="1">MCI (<italic toggle="yes">n</italic> = 42)</th>
                <th align="left" valign="top" rowspan="1" colspan="1">AD (<italic toggle="yes">n</italic> = 26)</th>
                <th align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Age (y)</td>
                <td align="left" rowspan="1" colspan="1">78.58 ± 6.12</td>
                <td align="left" rowspan="1" colspan="1">75.53 ± 5.43</td>
                <td align="left" rowspan="1" colspan="1">73.69 ± 6.20<sup>a</sup>
</td>
                <td align="left" rowspan="1" colspan="1">71.92 ± 7.74<sup>b</sup>
</td>
                <td align="char" char="." rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Gender (M/F)</td>
                <td align="left" rowspan="1" colspan="1">27/28</td>
                <td align="left" rowspan="1" colspan="1">15/30</td>
                <td align="left" rowspan="1" colspan="1">25/17</td>
                <td align="left" rowspan="1" colspan="1">13/13</td>
                <td align="char" char="." rowspan="1" colspan="1">0.103<xref rid="cns13716-note-0004" ref-type="table-fn">
<sup>†</sup>
</xref>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Education (y)</td>
                <td align="left" rowspan="1" colspan="1">15.96 ± 2.62</td>
                <td align="left" rowspan="1" colspan="1">16.64 ± 2.67</td>
                <td align="left" rowspan="1" colspan="1">15.86 ± 3.01</td>
                <td align="left" rowspan="1" colspan="1">15.08 ± 2.64</td>
                <td align="char" char="." rowspan="1" colspan="1">0.082</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic toggle="yes">APOE</italic>‐ε4 status (+/−)</td>
                <td align="left" rowspan="1" colspan="1">14/41</td>
                <td align="left" rowspan="1" colspan="1">12/33<sup>d</sup>
</td>
                <td align="left" rowspan="1" colspan="1">16/26<sup>e</sup>
</td>
                <td align="left" rowspan="1" colspan="1">19/7<sup>b</sup>
</td>
                <td align="char" char="." rowspan="1" colspan="1">&lt;0.001<xref rid="cns13716-note-0004" ref-type="table-fn">
<sup>†</sup>
</xref>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic toggle="yes">LRP1</italic>‐T status (+/−)</td>
                <td align="left" rowspan="1" colspan="1">10/45</td>
                <td align="left" rowspan="1" colspan="1">16/29</td>
                <td align="left" rowspan="1" colspan="1">17/25</td>
                <td align="left" rowspan="1" colspan="1">11/15</td>
                <td align="char" char="." rowspan="1" colspan="1">0.052<xref rid="cns13716-note-0004" ref-type="table-fn">
<sup>†</sup>
</xref>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MMSE</td>
                <td align="left" rowspan="1" colspan="1">28.75 ± 1.49</td>
                <td align="left" rowspan="1" colspan="1">29.00 ± 1.26</td>
                <td align="left" rowspan="1" colspan="1">27.17 ± 3.81<sup>c</sup>
</td>
                <td align="left" rowspan="1" colspan="1">22.65 ± 3.25<sup>bde</sup>
</td>
                <td align="char" char="." rowspan="1" colspan="1">&lt;0.001</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot id="cns13716-ntgp-0002">
            <fn id="cns13716-note-0003">
              <p>Abbreviations: AD, Alzheimer's disease; APOE, apolipoprotein E; CN, cognitively normal; LRP1, low‐density lipoprotein receptor‐related protein 1; M/F, male/female; MCI, mild cognitive impairment; MMSE, mini‐mental state examination; SCD, subjective cognitive decline.</p>
            </fn>
            <fn id="cns13716-note-0004">
              <label>†</label>
              <p>p values were obtained using χ<sup>2</sup> test; other p values were obtained by one‐way ANOVA, but if the Shapiro‐Wilk test or the Levene's homogeneity of variance test <italic toggle="yes">p</italic> &lt; 0.05, values were acquired by Kruskal‐Wallis test. Descriptive statistical values were presented as numbers for categorical variables and mean ± standard deviation for continuous variables. Post hoc analyses were performed with Bonferroni correction (<italic toggle="yes">p</italic> &lt; 0.05/6 = 0.0084): <sup>a</sup>, statistical difference between MCI group and CN group; <sup>b</sup>, statistical difference between AD group and CN group; <sup>c</sup>, statistical difference between MCI group and SCD group; <sup>d</sup>, statistical difference between AD group and SCD group; <sup>e</sup>, statistical difference between AD group and MCI group. No difference was found between SCD group and CN group.</p>
            </fn>
          </table-wrap-foot>
          <permissions>
            <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
          </permissions>
        </table-wrap>
      </sec>
      <sec id="cns13716-sec-0016">
        <label>3.2</label>
        <title>Main and interactive effects of <italic toggle="yes">LRP1</italic> genotype and disease status on the DMN</title>
        <p>The main effect of the disease status on the DMN was observed in the left temporoparietal joint (LTPJ), left inferior parietal cortex (LIPC), left and right posterior cingulate cortex (LPCC and RPCC), left retrosplenial cortex (LRSC), left precuneus/cuneus (LPCUN/LCUN), and right precuneus/cuneus (RPCUN/RCUN) (Figure <xref rid="cns13716-fig-0001" ref-type="fig">1A</xref>). Interestingly, the FC changes demonstrated a dynamic robust pattern along the entire disease process. The distribution pattern of FC in the LTPJ, LIPC, LPCC, and LRSC showed an inverted‐U shape, whereas FC changes in the LPCUN/LCUN, RPCC, and RPCUN/RCUN showed a U‐shape pattern (Figure <xref rid="cns13716-fig-0001" ref-type="fig">1B</xref>). The main effect of the <italic toggle="yes">LRP1</italic> genotype on the DMN was located in the left middle frontal gyrus (LMFG), LPCC, and RPCC (Figure <xref rid="cns13716-fig-0001" ref-type="fig">1C</xref>). In contrast with <italic toggle="yes">LRP1</italic>‐T non‐carriers, <italic toggle="yes">LRP1</italic>‐T carriers exhibited a stronger FC strength in these brain areas (Figure <xref rid="cns13716-fig-0001" ref-type="fig">1D</xref>).</p>
        <fig position="float" fig-type="FIGURE" id="cns13716-fig-0001">
          <label>FIGURE 1</label>
          <caption>
            <p>Main effect and interaction between disease status and <italic toggle="yes">LRP1</italic> genotype on the DMN across all subjects. (A) Brain regions with main effect of disease status on the DMN were identified and presented with node map. (B) Numerical representations of significant main effect of disease status on the DMN were illustrated in bar charts. (C) Brain regions significantly affected by <italic toggle="yes">LRP1</italic> genotypes on the DMN in <italic toggle="yes">LRP1</italic>‐T carriers (<italic toggle="yes">LRP1</italic> T<sup>+</sup>) compared with <italic toggle="yes">LRP1</italic>‐T non‐carriers (<italic toggle="yes">LRP1</italic> T<sup>−</sup>) were plotted with node map. (D) Numerical representations of the significant main effect of <italic toggle="yes">LRP1</italic> genotype on the DMN were described in bar charts. (E) Brain regions with significant interactive effects between <italic toggle="yes">LRP1</italic> genotype and disease on the DMN. (F) Linear trend of functional connectivity (FC) drawn via line charts represents the significant interactive effects of <italic toggle="yes">LRP1</italic> genotype and disease status on the DMN. Notably, the trajectory changes of mean FC in <italic toggle="yes">LRP1</italic>‐T carriers are opposite to <italic toggle="yes">LRP1</italic>‐T non‐carriers. Nodes’ colors and sizes in Figure A, C, and E indicate the plus and minus sign and variance of F value. Bar represents mean and standard error of mean, and each dot represents averaged functional connectivity of each participant within significant brain regions in Figure B and D. LRP1, low‐density lipoprotein receptor‐related protein 1; DMN, default mode network; CN, cognitively normal; SCD, subjective cognitive decline; MCI, mild cognitive impairment; AD, Alzheimer's disease; FC, functional connectivity; LTPJ, left temporoparietal junction; LIPC, left inferior parietal cortex; LPCC, left posterior cingulate cortex; LRSC, left retrosplenial cortex; LPCUN/LCUN, left precuneus and left cuneus; RPCC, right posterior cingulate cortex; RPCUN/RCUN, right precuneus and right cuneus; LMFG, left middle frontal gyrus; RDLPFC, right dorsal lateral prefrontal cortex.</p>
          </caption>
          <graphic xlink:href="CNS-27-1385-g005" position="anchor" id="jats-graphic-3"/>
        </fig>
        <p>The interactive effects of <italic toggle="yes">LRP1</italic> genotype and disease status on the DMN were also discovered in the LMFG, LPCC, RPCC, LRSC, and right dorsolateral prefrontal cortex (RDLPFC) (Figure <xref rid="cns13716-fig-0001" ref-type="fig">1E</xref>). More importantly, unlike <italic toggle="yes">LRP1</italic>‐T non‐carriers, the FC of the <italic toggle="yes">LRP1</italic>‐T carriers displayed opposite trajectory changes in these brain regions across the entire disease process, specifically between the SCD and MCI stages. The <italic toggle="yes">LRP1</italic>‐T carriers showed increased connectivity in the LMFG and decreased connectivity in the LPCC, LRSC, RDLPFC, and RPCC; nevertheless, the <italic toggle="yes">LRP1</italic>‐T non‐carriers demonstrated a relatively stable change with the progression of disease (Figure <xref rid="cns13716-fig-0001" ref-type="fig">1F</xref>). The main effects and interaction of <italic toggle="yes">LRP1</italic> genotype and disease status were majorly focused at the core hubs of the frontal‐parietal network. Comprehensive descriptions of brain regions and their FC differences among different groups are illustrated in Tables S1 and S2.</p>
      </sec>
      <sec id="cns13716-sec-0017">
        <label>3.3</label>
        <title>Relationship between altered FC and cognitive performance</title>
        <p>As shown in Figure <xref rid="cns13716-fig-0002" ref-type="fig">2</xref>, the linear regression analyses indicated that disrupted FCs in brain regions of LMFG, RPCC, and LIPC were significantly correlated with the MMSE scores across all groups in the <italic toggle="yes">LRP1</italic>‐T carriers but not in the non‐carriers. The FC of LMFG negatively correlated with the MMSE score, indicating an increased FC corresponding to a declining cognitive score. Nonetheless, the FCs of RPCC and LIPC positively correlated with MMSE scores, that is, greater FCs corresponded to higher cognitive scores.</p>
        <fig position="float" fig-type="FIGURE" id="cns13716-fig-0002">
          <label>FIGURE 2</label>
          <caption>
            <p>Linear regression analyses between functional connectivity and cognitive performance in the <italic toggle="yes">LRP1</italic>‐T carriers. (A) Brain nodes diagrams represented altered functional connectivity (FC) values in the regions of LMFG, RPCC, and LIPC. (B) Brain regions of LMFG, RPCC, and LIPC with altered FC could significantly affect the MMSE scores in the <italic toggle="yes">LRP1</italic>‐T carriers but not in <italic toggle="yes">LRP1</italic>‐T non‐carriers. The individual raw scores of MMSE were transformed to z scores to assure data normally distributed. Z transformation formula is z = (x ‐ μ) / σ, where x is a specific value, μ is the mean value, and σ is the standard deviation. The significance level was set at <italic toggle="yes">p </italic>&lt; 0.05. LMFG, left middle frontal gyrus; RPCC, right posterior cingulate cortex; LIPC, left inferior parietal cortex; MMSE, mini‐mental state examination.</p>
          </caption>
          <graphic xlink:href="CNS-27-1385-g003" position="anchor" id="jats-graphic-5"/>
        </fig>
      </sec>
      <sec id="cns13716-sec-0018">
        <label>3.4</label>
        <title>Relationships among <italic toggle="yes">LRP1</italic>, <italic toggle="yes">APOE</italic>, and MMSE</title>
        <p>The moderation effect analysis revealed that <italic toggle="yes">APOE</italic> genotype and <italic toggle="yes">LRP1</italic> genotype regulated the effects of each other on cognitive performance across all subjects. Figure <xref rid="cns13716-fig-0003" ref-type="fig">3A</xref> shows the moderation model of <italic toggle="yes">APOE</italic> genotype affecting the effect of <italic toggle="yes">LRP1</italic> genotype on MMSE scores. As presented in Figure <xref rid="cns13716-fig-0003" ref-type="fig">3B, a</xref> relationship between <italic toggle="yes">LRP1</italic> genotype and MMSE scores was moderated by <italic toggle="yes">APOE</italic> genotype; that is because the interaction of <italic toggle="yes">LRP1</italic> genotype and <italic toggle="yes">APOE</italic> genotype significantly affected cognitive performance (β = 0.946, <italic toggle="yes">p</italic> = 0.004). Similarly, Figure <xref rid="cns13716-fig-0003" ref-type="fig">3C</xref> displays the model of the <italic toggle="yes">LRP1</italic> genotype as a moderator affecting the casual correlation of <italic toggle="yes">APOE</italic> genotype to MMSE scores. The relationship between <italic toggle="yes">APOE</italic> genotype and MMSE scores depended on the moderation of the <italic toggle="yes">LRP1</italic> genotype (Figure <xref rid="cns13716-fig-0003" ref-type="fig">3D</xref>). Specifically, <italic toggle="yes">APOE</italic> genotype and <italic toggle="yes">LRP1</italic> genotype interaction significantly affected cognition (β = 0.946, <italic toggle="yes">p</italic> = 0.004). Therefore, the effects of <italic toggle="yes">LRP1</italic> and <italic toggle="yes">APOE</italic> on cognition are moderated dependent on each other.</p>
        <fig position="float" fig-type="FIGURE" id="cns13716-fig-0003">
          <label>FIGURE 3</label>
          <caption>
            <p>The relationships between <italic toggle="yes">LRP1</italic>, <italic toggle="yes">APOE</italic>, and MMSE across all subjects. (A) The moderation model of <italic toggle="yes">APOE</italic> genotype influencing the effect of <italic toggle="yes">LRP1</italic> genotype on MMSE scores. (B) The statistical diagram presents the effects of <italic toggle="yes">LRP1</italic> genotype, <italic toggle="yes">APOE</italic> genotype, and interaction of <italic toggle="yes">LRP1</italic> and <italic toggle="yes">APOE</italic> on MMSE scores. Moderation effect analysis revealed that <italic toggle="yes">APOE</italic> could modulate the relationship between <italic toggle="yes">LRP1</italic> and cognitive performance. (C) The moderation model of <italic toggle="yes">LRP1</italic> genotype influencing the effect of <italic toggle="yes">APOE</italic> genotype on MMSE scores. (D) The statistical diagram presents the effects of <italic toggle="yes">APOE</italic> genotype, <italic toggle="yes">LRP1</italic> genotype, and interaction of <italic toggle="yes">LRP1</italic> and <italic toggle="yes">APOE</italic> on MMSE scores. Moderation effect analysis revealed that <italic toggle="yes">LRP1</italic> could modulate the relationship between <italic toggle="yes">APOE</italic> and cognitive performance. (E) The interaction of <italic toggle="yes">LRP1</italic> genotype (T<sup>−</sup>/T<sup>+</sup>) and <italic toggle="yes">APOE</italic> genotype (ε4<sup>−</sup>/ε4<sup>+</sup>) on z‐transformed MMSE values. Bar represents mean and standard error of mean, and each dot represents z‐transformed MMSE scores of each participant within every genotype group. The main effect of <italic toggle="yes">LRP1</italic> on MMSE was insignificant (<italic toggle="yes">F</italic> = 0.510, <italic toggle="yes">p</italic> = 0.476), but that of <italic toggle="yes">APOE</italic> was significant (<italic toggle="yes">F</italic> = 6.877, <italic toggle="yes">p</italic> = 0.010). *<italic toggle="yes">p </italic>&lt; 0.05. (F) The interactive effect of <italic toggle="yes">LRP1</italic> genotype (T<sup>−</sup>/T<sup>+</sup>) and <italic toggle="yes">APOE</italic> genotype (ε4<sup>−</sup>/ε4<sup>+</sup>) on MMSE scores was significant (<italic toggle="yes">F</italic> = 8.546, <italic toggle="yes">p</italic> = 0.004). Interactive effect analysis revealed that the effect of <italic toggle="yes">LRP1</italic> on MMSE was dependent on different levels of <italic toggle="yes">APOE</italic> genotype. APOE, apolipoprotein E; LRP1, low‐density lipoprotein receptor‐related protein 1; MMSE, mini‐mental state examination.</p>
          </caption>
          <graphic xlink:href="CNS-27-1385-g004" position="anchor" id="jats-graphic-7"/>
        </fig>
        <p>Furthermore, the interactive effect analysis disclosed that the effect of <italic toggle="yes">LRP1</italic> genotype on MMSE scores was dependent on different levels of <italic toggle="yes">APOE</italic> genotype. Figure <xref rid="cns13716-fig-0003" ref-type="fig">3E</xref> presents the main effect of <italic toggle="yes">LRP1</italic> on MMSE was insignificant (<italic toggle="yes">F</italic> = 0.510, <italic toggle="yes">p</italic> = 0.476), yet that of <italic toggle="yes">APOE</italic> was significant (<italic toggle="yes">F</italic> = 6.877, <italic toggle="yes">p</italic> = 0.010). As evident in Figure <xref rid="cns13716-fig-0003" ref-type="fig">3F</xref>, the interactive effect of <italic toggle="yes">LRP1</italic> genotype and <italic toggle="yes">APOE</italic> genotype on MMSE scores was important (<italic toggle="yes">F</italic> = 8.546, <italic toggle="yes">p</italic> = 0.004). Since the <italic toggle="yes">LRP1</italic> genotype shows opposing effects at both levels of <italic toggle="yes">APOE</italic> genotype, the main effect of the <italic toggle="yes">LRP1</italic> genotype is balanced out. Nonetheless, the <italic toggle="yes">LRP1</italic> genotype affects MMSE (see moderation effect above). These details of moderation and interactive effect are shown in Tables S3 and S4.</p>
      </sec>
      <sec id="cns13716-sec-0019">
        <label>3.5</label>
        <title>Stage‐dependent neuroimaging biomarker of FC for classifying AD spectrum population</title>
        <p>As displayed in Figure <xref rid="cns13716-fig-0004" ref-type="fig">4</xref>, ROC analysis indicated that FC of numerous brain regions produced a strong power for classifying different disease stages specifically in the <italic toggle="yes">LRP1</italic>‐T carriers but not in non‐carriers. In the brain area of LMFG, FC was detected as the predictive variable with AUC of 0.744 to discriminate SCD from CN, AUC of 0.771 to discriminate MCI from CN, AUC of 0.891 to discriminate AD from CN, and AUC of 0.756 to discriminate AD from SCD. Also, FC of LIPC helped discriminate AD from MCI and FC of RPCC discriminate MCI from CN. Besides, all AUC values were more than 0.7, indicating the strong power of these predictive variables to discriminate disease stages.</p>
        <fig position="float" fig-type="FIGURE" id="cns13716-fig-0004">
          <label>FIGURE 4</label>
          <caption>
            <p>Stage‐dependent neuroimaging biomarker for classifying AD spectrum population in the <italic toggle="yes">LRP1</italic>‐T carriers. Only in the <italic toggle="yes">LRP1</italic>‐T carriers, functional connectivity (FC) values of numerous brain regions were found to be predictive variables in classifying SCD from CN (AUC = 0.744, <italic toggle="yes">p</italic> = 0.040 for LMFG), MCI from CN (AUC = 0.771, <italic toggle="yes">p</italic> = 0.020 for LMFG), AD from CN (AUC = 0.891, <italic toggle="yes">p</italic> = 0.002 for LMFG), AD from SCD (AUC = 0.756, <italic toggle="yes">p</italic> = 0.030 for LMFG), AD from MCI (AUC = 0.762, <italic toggle="yes">p</italic> = 0.020 for LIPC), MCI from CN (AUC = 0.753, <italic toggle="yes">p</italic> = 0.030 for RPCC). ROC, receiver operating characteristic; AUC, area under curve; LMFG, left middle frontal gyrus; LIPC, left inferior parietal cortex; RPCC, right posterior cingulate cortex; CN, cognitively normal; SCD, subjective cognitive decline; MCI, mild cognitive impairment; AD, Alzheimer's disease.</p>
          </caption>
          <graphic xlink:href="CNS-27-1385-g002" position="anchor" id="jats-graphic-9"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="cns13716-sec-0020">
      <label>4</label>
      <title>DISCUSSION</title>
      <p>This study demonstrates the interactive effect of <italic toggle="yes">LRP1</italic> genotype and disease status on the DMN that primarily focused on the core hubs of the frontal‐parietal network and shows the opposite trajectory changes of FC within DMN in the <italic toggle="yes">LRP1</italic>‐T carriers compared with non‐carriers. This dichotomous pattern suggests that these vulnerable brain regions across the AD spectrum undergo different temporal and spatial patterns of progression. More importantly, we found that FCs correlated with cognitive performance in the <italic toggle="yes">LRP1</italic>‐T carriers but not in the <italic toggle="yes">LRP1</italic>‐T non‐carriers. <italic toggle="yes">APOE</italic> and <italic toggle="yes">LRP1</italic> could regulate the effect of each other on cognitive performance. Furthermore, we confirmed that the disrupted FCs potentially classify the AD spectrum population and act as a potential neuroimaging biomarker, specifically in the <italic toggle="yes">LRP1</italic>‐T carriers. These findings imply that the <italic toggle="yes">LRP1</italic> gene rs1799986 variant polymorphism consistently affects the DMN FC changes across the AD spectrum population and provides a stage‐dependent neuroimaging biomarker for early identification of the AD spectrum.</p>
      <p>We detected the neural correlates of the <italic toggle="yes">LRP1</italic> genotype and disease status on the DMN along the AD spectrum. These brain regions belong to the frontal‐parietal network, which governs the cascade of attentional processes underlying the complex cognitive functions.<xref rid="cns13716-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="cns13716-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="cns13716-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Besides, they are vulnerable areas of AD progression, as reported formerly.<xref rid="cns13716-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="cns13716-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="cns13716-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="cns13716-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> Interestingly, the distribution pattern of FC in the LTPJ, LIPC, LPCC, and LRSC exhibited an inverted‐U shape, suggesting that the altered FC strengths of these regions may compensate for cognitive decline in the MCI stage but decompensation occurred in the AD stage.<xref rid="cns13716-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> The FC changes in the LPCUN/LCUN, RPCC, and RPCUN/RCUN manifested a U‐shape pattern, indicating a disruption in these regions‐related networks at the early stage of AD; however, compensation occurred until the AD stage.<xref rid="cns13716-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>, <xref rid="cns13716-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> Then, the FC strength of regions affected by the <italic toggle="yes">LRP1</italic> genotype presented an increased distributed tendency in the <italic toggle="yes">LRP1</italic>‐T carriers compared with non‐carriers. This T allele dose‐dependent distribution suggested that compensation mechanism occurred in the LPCC, RPCC, and LMFG. Notably, the posterior cingulate cortex (PCC) is an identical brain area influenced by both the <italic toggle="yes">LRP1</italic> genotype and disease status. As a crucial neural node within DMN, the PCC has been extensively studied in AD spectrum.<xref rid="cns13716-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref>, <xref rid="cns13716-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>, <xref rid="cns13716-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref>, <xref rid="cns13716-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref> It is considered one of the earliest regions to be affected by AD based on the proposed hypothesis of cascading network failure<xref rid="cns13716-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="cns13716-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> with early connectivity decreases<xref rid="cns13716-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> and directional receiving or transmitting information.<xref rid="cns13716-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>
</p>
      <p>Specifically, the <italic toggle="yes">LRP1</italic>‐T carriers and non‐carriers yield opposite FC changes within DMN across the entire disease process, which might be interpreted by different neural mechanisms underlying AD progression. Notably, qualitative changes with different trajectories occurred in FC during the transition from SCD to MCI. This indicates that gene effects were mainly reflected in this selectively vulnerable transition process. Nevertheless, the genetic profile of pre‐dementia is significantly underexplored. Genetic studies in longitudinal SCD and MCI follow‐up may thus provide novel therapeutic targets and improve the existing knowledge of AD.<xref rid="cns13716-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> The <italic toggle="yes">LRP1</italic>‐T carriers revealed an increased FC in the LMFG and decreased FCs in the LPCC, LRSC, RDLPFC, and RPCC, whereas, the <italic toggle="yes">LRP1</italic>‐T non‐carriers presented a relatively stable change with the progression of disease. This <italic toggle="yes">LRP1</italic> genotype‐related distribution suggested that the increased FC in LMFG likely occurs in <italic toggle="yes">LRP1</italic>‐T carriers at a higher risk of AD, which is considered compensatory reallocation of cognitive resources since it is associated with better cognitive performance.<xref rid="cns13716-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> However, the decreased FCs in LPCC, LRSC, RDLPFC, and RPCC seemingly occur in <italic toggle="yes">LRP1</italic>‐T carriers at a higher risk of AD. This declining trajectory is broadly consistent with disease progression. On the other hand, the FC of <italic toggle="yes">LRP1</italic>‐T non‐carriers has a relatively stable change across four groups, indicating that the <italic toggle="yes">LRP1</italic>‐C allele might be a protective factor that prevents functional deterioration.</p>
      <p>Moreover, the FCs of LMFG, RPCC, and LIPC correlated with MMSE scores in the <italic toggle="yes">LRP1</italic>‐T carriers but not in the non‐carriers. This indicates that the presence of risk T allele might partly influence the connection of the brain network with behavior performance. The FC of LMFG negatively correlated with MMSE, which might be explained as FC compensation for cognitive decline as above.<xref rid="cns13716-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> Besides, we detected positive correlations of the RPCC and LIPC FCs with MMSE. This increased FC is broadly consistent with better cognitive performance at earlier disease stages. These findings highlight the role of the <italic toggle="yes">LRP1</italic> genotype in the intrinsic brain function of the AD spectrum population.</p>
      <p>As mentioned above, LRP1 is a key receptor of APOE, and APOE mediates Aβ pathology depending on LRP1.<xref rid="cns13716-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> This means that their corresponding genes may be inextricably linked to each other. Previous research also verified that <italic toggle="yes">APOE</italic>‐ε4 is linked to cognitive phenotypes across the AD spectrum.<xref rid="cns13716-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> In the present study, two simple moderation analyses identified that the <italic toggle="yes">LRP1</italic> genotype and <italic toggle="yes">APOE</italic> genotype could regulate the effect of each other on cognitive performance. This implies the importance of removing the <italic toggle="yes">APOE</italic> effect when investigating the relationships of <italic toggle="yes">LRP1</italic> with network and cognition. Further, an interactive effect analysis was performed; this confirmed that the impact of <italic toggle="yes">LRP1</italic> on cognitive scores depends on different levels (opposing direction) of the <italic toggle="yes">APOE</italic> genotype; hence, it is balanced out (<italic toggle="yes">p</italic> &gt; 0.05) in the interaction model. <italic toggle="yes">APOE</italic>‐ε4<sup>+</sup> could promote cognitive decline even with the absence of the <italic toggle="yes">LRP1</italic>‐T allele, whereas, <italic toggle="yes">APOE</italic>‐ε4<sup>−</sup> synergy with <italic toggle="yes">LRP1</italic>‐T<sup>−</sup> might act a protective role for a higher cognitive function. These findings indicate that <italic toggle="yes">APOE</italic>‐ε4 is a consistent and strong genetic risk factor for AD. Besides, a strong <italic toggle="yes">APOE</italic> effect may bridge the connection between the <italic toggle="yes">LRP1</italic> genotype and the complex brain cognition as well as provide a novel outlook on the complex mechanism underlying gene‐behavior interaction.</p>
      <p>Several studies have confirmed that brain network variables could be used as predictors in the classification of diseases.<xref rid="cns13716-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref>, <xref rid="cns13716-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>, <xref rid="cns13716-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> The FC values have been applied in distinguishing AD, MCI from CN subjects.<xref rid="cns13716-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> Our group discovered that FCs of numerous brain regions including LMFG, LIPC, and RPCC could classify different disease stages of AD spectrum among all LRP1‐T carriers but not in non‐carriers. Specifically, the FC of LMFG could even classify SCD from the CN group with an AUC value of 0.744. Besides, all AUC values were more than 0.7, suggesting that FCs could yield high accuracy in classifying the AD spectrum. Also, the FCs of LMFG could discriminate SCD, MCI, AD from CN, and AD from SCD. Further, the SVM model cross‐validated this discriminating capacity. This suggests that the LMFG may be a vulnerable region susceptible to genetic influence. It is noteworthy that no intrinsic connectivity could distinguish four groups at one time. As such, the disrupted FC can serve as a stage‐dependent neuroimaging biomarker in classifying the AD spectrum.</p>
      <p>This study has worth‐mentioning limitations that should be addressed in future research. First, the study design is cross‐sectional; thus, incorporating follow‐up data is essential to validate the predictive power of FCs for AD spectrum progression. Secondly, a recent study revealed temporal dynamic feature in AD<xref rid="cns13716-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>; thus, a prominent future direction might be necessary to evaluate the effect of biological factors on FC dynamics across the progression of AD. Thirdly, LRP1 mediated vascular clearance of Aβ from the brain<xref rid="cns13716-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref>; hence, abnormal vascular function might induce cerebral hemodynamic dysregulation and further aggregate Aβ deposition. Previous studies have reported that microvascular lesions altered Aβ plaques<xref rid="cns13716-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>; local cerebral blood flow responses to neuronal activity were impaired in AD<xref rid="cns13716-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>; and neurovascular dysregulation even occurred in middle‐aged <italic toggle="yes">APOE</italic>‐ε4 carriers.<xref rid="cns13716-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref> Nevertheless, aerobic exercise significantly improved hippocampal blood flow in hypertensive <italic toggle="yes">APOE</italic>‐ε4 carriers, which might be beneficial for individuals at high risk of AD.<xref rid="cns13716-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> Therefore, future work will focus on cerebral vascular issues and design effective intervention strategies to delay the disease progression in preclinical stage of AD. Fourthly, hypotheses such as autophagy<xref rid="cns13716-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref> and gut dysbiosis<xref rid="cns13716-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref> represented distinct signaling pathways in AD, and more genes were implicated in Aβ clearance, including <italic toggle="yes">APOE</italic>,<xref rid="cns13716-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref> clusterin,<xref rid="cns13716-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref> α2‐Macroglobulin,<xref rid="cns13716-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> and triggering receptor expressed on myeloid cells 2.<xref rid="cns13716-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref> Thus, future research will focus on pathway‐based polygenic effects on brain networks that can better translate the underlying mechanism of AD.</p>
    </sec>
    <sec sec-type="conclusions" id="cns13716-sec-0021">
      <label>5</label>
      <title>CONCLUSION</title>
      <p>In conclusion, this paper first found the <italic toggle="yes">LRP1</italic> gene rs1799986 variant polymorphism could consistently affect DMN patterns across the AD spectrum population. <italic toggle="yes">APOE</italic> regulated the effect of <italic toggle="yes">LRP1</italic> on cognitive performance. The disrupted FCs might be used as a stage‐dependent neuroimaging biomarker in classifying the AD spectrum. These findings provide novel insights into the potential mechanism underlying cognitive impairment in AD spectrum progression, and the identification of intervention targets based on genetic risk variants may offer a sneak peek at future research direction.</p>
    </sec>
    <sec sec-type="COI-statement" id="cns13716-sec-0023">
      <title>CONFLICT OF INTEREST</title>
      <p>No authors have any possible conflict of interest.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material id="cns13716-sup-0001" position="float" content-type="local-data">
        <caption>
          <p>Supplementary Material</p>
        </caption>
        <media xlink:href="CNS-27-1385-s001.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="cns13716-sec-0022">
      <title>ACKNOWLEDGEMENT</title>
      <p>Data collection and sharing for this project were funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH‐12‐2‐0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc; Biogen Idec Inc; Bristol‐Myers Squibb Company; Eisai Inc; Elan Pharmaceuticals, Inc; Eli Lilly and Company; EuroImmun; F. Homann‐La Roche Ltd and its affiliated company Genentech, Inc; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research &amp; Development, LLC.; Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC.; Medpace, Inc; Merck &amp; Co., Inc; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc; Piramal Imaging; Servier; Synarc Inc; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (<ext-link xlink:href="http://www.fnih.org" ext-link-type="uri">http://www.fnih.org</ext-link>). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.</p>
    </ack>
    <ref-list content-type="cited-references" id="cns13716-bibl-0001">
      <title>REFERENCES</title>
      <ref id="cns13716-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0001">
<string-name>
<surname>Harris‐White</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Frautschy</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Low density lipoprotein receptor‐related proteins (LRPs), Alzheimer's and cognition</article-title>. <source>Curr Drug Target CNS Neurol Disord</source>. <year>2005</year>;<volume>4</volume>(<issue>5</issue>):<fpage>469</fpage>‐<lpage>480</lpage>.</mixed-citation>
      </ref>
      <ref id="cns13716-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0002">
<string-name>
<surname>Sagare</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Deane</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zlokovic</surname>
<given-names>BV</given-names>
</string-name>. <article-title>Low‐density lipoprotein receptor‐related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities</article-title>. <source>Pharmacol Ther</source>. <year>2012</year>;<volume>136</volume>(<issue>1</issue>):<fpage>94</fpage>‐<lpage>105</lpage>.<pub-id pub-id-type="pmid">22820095</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0003">
<string-name>
<surname>Hardy</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Higgins</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Alzheimer's disease: the amyloid cascade hypothesis</article-title>. <source>Science</source>. <year>1992</year>;<volume>256</volume>(<issue>5054</issue>):<fpage>184</fpage>‐<lpage>185</lpage>.<pub-id pub-id-type="pmid">1566067</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0004">
<string-name>
<surname>Liu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Trotter</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age‐dependent synapse loss and neurodegeneration</article-title>. <source>J Neurosci</source>. <year>2010</year>;<volume>30</volume>(<issue>50</issue>):<fpage>17068</fpage>‐<lpage>17078</lpage>.<pub-id pub-id-type="pmid">21159977</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0005">
        <label>5</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0005">
<string-name>
<surname>Kang</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Saitoh</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Genetic association of the low‐density lipoprotein receptor‐related protein gene (LRP), an apolipoprotein E receptor, with late‐onset Alzheimer's disease</article-title>. <source>Neurology</source>. <year>1997</year>;<volume>49</volume>(<issue>1</issue>):<fpage>56</fpage>‐<lpage>61</lpage>.<pub-id pub-id-type="pmid">9222170</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0006">
        <label>6</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0006">
<string-name>
<surname>Lambert</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Wavrant‐De Vrièze</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Amouyel</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chartier‐Harlin</surname>
<given-names>MC</given-names>
</string-name>. <article-title>Association at LRP gene locus with sporadic late‐onset Alzheimer's disease</article-title>. <source>Lancet</source>. <year>1998</year>;<volume>351</volume>(<issue>9118</issue>):<fpage>1787</fpage>‐<lpage>1788</lpage>.<pub-id pub-id-type="pmid">9635959</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0007">
        <label>7</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0007">
<string-name>
<surname>Kolsch</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ptok</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Mohamed</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Association of the C766T polymorphism of the low‐density lipoprotein receptor‐related protein gene with Alzheimer's disease</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source>. <year>2003</year>;<volume>121B</volume>(<issue>1</issue>):<fpage>128</fpage>‐<lpage>130</lpage>.<pub-id pub-id-type="pmid">12898587</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0008">
        <label>8</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0008">
<string-name>
<surname>Bian</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>TW</given-names>
</string-name>, et al. <article-title>Association study of the A2M and LRP1 Genes with Alzheimer disease in the Han Chinese</article-title>. <source>Biol Psychiat</source>. <year>2005</year>;<volume>58</volume>(<issue>9</issue>):<fpage>731</fpage>‐<lpage>737</lpage>.<pub-id pub-id-type="pmid">16040006</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0009">
        <label>9</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0009">
<string-name>
<surname>Jansen</surname>
<given-names>IE</given-names>
</string-name>, <string-name>
<surname>Savage</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Genome‐wide meta‐analysis identifies new loci and functional pathways influencing Alzheimer's disease risk</article-title>. <source>Nat Genet</source>. <year>2019</year>;<volume>51</volume>(<issue>3</issue>):<fpage>404</fpage>‐<lpage>413</lpage>.<pub-id pub-id-type="pmid">30617256</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0010">
        <label>10</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0010">
<string-name>
<surname>Kunkle</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Grenier‐Boley</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sims</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Genetic meta‐analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing</article-title>. <source>Nat Genet</source>. <year>2019</year>;<volume>51</volume>(<issue>3</issue>):<fpage>414</fpage>‐<lpage>430</lpage>.<pub-id pub-id-type="pmid">30820047</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0011">
        <label>11</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0011">
<string-name>
<surname>Marioni</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Harris</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name> et al. <article-title>GWAS on family history of Alzheimer's disease</article-title>. <source>Translational Psychiatry</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>99</fpage>.<pub-id pub-id-type="pmid">29777097</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0012">
        <label>12</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0012">
<string-name>
<surname>Kang</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Pietrzik</surname>
<given-names>CU</given-names>
</string-name>, <string-name>
<surname>Baum</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Modulation of amyloid beta‐protein clearance and Alzheimer's disease susceptibility by the LDL receptor‐related protein pathway</article-title>. <source>J Clin Investig</source>. <year>2000</year>;<volume>106</volume>(<issue>9</issue>):<fpage>1159</fpage>‐<lpage>1166</lpage>.<pub-id pub-id-type="pmid">11067868</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0013">
        <label>13</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0013">
<string-name>
<surname>Sultana</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Banks</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Butterfield</surname>
<given-names>DA</given-names>
</string-name>. <article-title>Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease</article-title>. <source>J Neurosci Res</source>. <year>2010</year>;<volume>88</volume>(<issue>3</issue>):<fpage>469</fpage>‐<lpage>477</lpage>.<pub-id pub-id-type="pmid">19774677</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0014">
        <label>14</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0014">
<string-name>
<surname>Van Gool</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Storck</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Reekmans</surname>
<given-names>SM</given-names>
</string-name> et al. <article-title>LRP1 Has a predominant role in production over clearance of Abeta in a mouse model of Alzheimer's disease</article-title>. <source>Mol Neurobiol</source>. <year>2019</year>;<volume>56</volume>(<issue>10</issue>):<fpage>7234</fpage>‐<lpage>7245</lpage>.<pub-id pub-id-type="pmid">31004319</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0015">
        <label>15</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0015">
<string-name>
<surname>Storck</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Pietrzik</surname>
<given-names>CU</given-names>
</string-name>. <article-title>Endothelial LRP1 ‐ A potential target for the treatment of Alzheimer's disease : Theme: drug discovery, development and delivery in Alzheimer's disease guest Editor: Davide Brambilla</article-title>. <source>Pharm Res</source>. <year>2017</year>;<volume>34</volume>(<issue>12</issue>):<fpage>2637</fpage>‐<lpage>2651</lpage>.<pub-id pub-id-type="pmid">28948494</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0016">
        <label>16</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0016">
<string-name>
<surname>Rauch</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Luna</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Guzman</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>LRP1 is a master regulator of tau uptake and spread</article-title>. <source>Nature</source>. <year>2020</year>;<volume>580</volume>(<issue>7803</issue>):<fpage>381</fpage>‐<lpage>385</lpage>.<pub-id pub-id-type="pmid">32296178</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0017">
        <label>17</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0017">
<string-name>
<surname>Seok</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shin</surname>
<given-names>E</given-names>
</string-name> et al. <article-title>Low‐dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus</article-title>. <source>Sci Rep</source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>4414</fpage>.<pub-id pub-id-type="pmid">30867485</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0018">
        <label>18</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0018">
<string-name>
<surname>Tachibana</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Holm</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>CC</given-names>
</string-name>, et al. <article-title>APOE4‐mediated amyloid‐beta pathology depends on its neuronal receptor LRP1</article-title>. <source>J Clin Invest</source>. <year>2019</year>;<volume>129</volume>(<issue>3</issue>):<fpage>1272</fpage>‐<lpage>1277</lpage>.<pub-id pub-id-type="pmid">30741718</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0019">
        <label>19</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0019">
<string-name>
<surname>Strickland</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Holtzman</surname>
<given-names>DM</given-names>
</string-name>. <article-title>Dr. Jekyll and Mr. Hyde: ApoE explains opposing effects of neuronal LRP1</article-title>. <source>J Clin Invest</source>. <year>2019</year>;<volume>129</volume>(<issue>3</issue>):<fpage>969</fpage>–<lpage>971</lpage>.<pub-id pub-id-type="pmid">30741722</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0020">
        <label>20</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0020">
<string-name>
<surname>Jones</surname>
<given-names>DT</given-names>
</string-name>, <string-name>
<surname>Knopman</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Gunter</surname>
<given-names>JL</given-names>
</string-name>, et al. <article-title>Cascading network failure across the Alzheimer's disease spectrum</article-title>. <source>Brain</source>. <year>2016</year>;<volume>139</volume>(<issue>Pt 2</issue>):<fpage>547</fpage>‐<lpage>562</lpage>.<pub-id pub-id-type="pmid">26586695</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0021">
        <label>21</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0021">
<string-name>
<surname>Damoiseaux</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Prater</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>BL</given-names>
</string-name>, <string-name>
<surname>Greicius</surname>
<given-names>MD</given-names>
</string-name>. <article-title>Functional connectivity tracks clinical deterioration in Alzheimer's disease</article-title>. <source>Neurobiol Aging</source>. <year>2012</year>;<volume>33</volume>(<issue>4</issue>):<fpage>828 e19‐30</fpage>.</mixed-citation>
      </ref>
      <ref id="cns13716-bib-0022">
        <label>22</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0022">
<string-name>
<surname>Palmqvist</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Scholl</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Strandberg</surname>
<given-names>O</given-names>
</string-name> et al. <article-title>Earliest accumulation of beta‐amyloid occurs within the default‐mode network and concurrently affects brain connectivity</article-title>. <source>Nat Commun</source>. <year>2017</year>;<volume>8</volume>(<issue>1</issue>):<fpage>1214</fpage>.<pub-id pub-id-type="pmid">29089479</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0023">
        <label>23</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0023">
<string-name>
<surname>Aisen</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Petersen</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Donohue</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Weiner</surname>
<given-names>MW</given-names>
</string-name>. <article-title>Alzheimer's disease neuroimaging initiative 2 clinical core: progress and plans</article-title>. <source>Alzheimers Dement</source>. <year>2015</year>;<volume>11</volume>(<issue>7</issue>):<fpage>734</fpage>‐<lpage>739</lpage>.<pub-id pub-id-type="pmid">26194309</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0024">
        <label>24</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0024">
<string-name>
<surname>Saykin</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Foroud</surname>
<given-names>TM</given-names>
</string-name>, et al. <article-title>Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans</article-title>. <source>Alzheimers Dement</source>. <year>2010</year>;<volume>6</volume>(<issue>3</issue>):<fpage>265</fpage>‐<lpage>273</lpage>.<pub-id pub-id-type="pmid">20451875</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0025">
        <label>25</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0025">
<string-name>
<surname>Hayes</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Rockwood</surname>
<given-names>NJ</given-names>
</string-name>. <article-title>Regression‐based statistical mediation and moderation analysis in clinical research: Observations, recommendations, and implementation</article-title>. <source>Behav Res Ther</source>. <year>2017</year>;<volume>98</volume>:<fpage>39</fpage>‐<lpage>57</lpage>.<pub-id pub-id-type="pmid">27865431</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0026">
        <label>26</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0026">
<string-name>
<surname>Chang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>C</given-names>
</string-name>. <article-title>LIBSVM: A library for support vector machines</article-title>. <source>ACM Trans Intell Syst Technol</source>. <year>2011</year>;<volume>2</volume>(<issue>3</issue>):<fpage>1</fpage>–<lpage>27</lpage>.</mixed-citation>
      </ref>
      <ref id="cns13716-bib-0027">
        <label>27</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0027">
<string-name>
<surname>Johnson</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>King‐Stephens</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Weber</surname>
<given-names>PB</given-names>
</string-name>, <string-name>
<surname>Laxer</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Knight</surname>
<given-names>RT</given-names>
</string-name>. <article-title>Spectral imprints of working memory for everyday associations in the frontoparietal network</article-title>. <source>Front Syst Neurosci</source>. <year>2018</year>;<volume>12</volume>:<fpage>65</fpage>.<pub-id pub-id-type="pmid">30670953</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0028">
        <label>28</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0028">
<string-name>
<surname>Duncan</surname>
<given-names>J</given-names>
</string-name>. <article-title>The structure of cognition: attentional episodes in mind and brain</article-title>. <source>Neuron</source>. <year>2013</year>;<volume>80</volume>(<issue>1</issue>):<fpage>35</fpage>‐<lpage>50</lpage>.<pub-id pub-id-type="pmid">24094101</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0029">
        <label>29</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0029">
<string-name>
<surname>Stoewer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ku</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Goense</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Frontoparietal activity with minimal decision and control in the awake macaque at 7 T</article-title>. <source>Magn Reson Imaging</source>. <year>2010</year>;<volume>28</volume>(<issue>8</issue>):<fpage>1120</fpage>‐<lpage>1128</lpage>.<pub-id pub-id-type="pmid">20117895</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0030">
        <label>30</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0030">
<string-name>
<surname>Qi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>X</given-names>
</string-name>. <article-title>Primary disruption of the memory‐related subsystems of the default mode network in Alzheimer's disease: resting‐state functional connectivity MRI study</article-title>. <source>Front Aging Neurosci</source>. <year>2018</year>;<volume>10</volume>:<fpage>344</fpage>.<pub-id pub-id-type="pmid">30429784</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0031">
        <label>31</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0031">
<string-name>
<surname>Dillen</surname>
<given-names>KNH</given-names>
</string-name>, <string-name>
<surname>Jacobs</surname>
<given-names>HIL</given-names>
</string-name>, <string-name>
<surname>Kukolja</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Functional disintegration of the default mode network in prodromal Alzheimer's disease</article-title>. <source>J Alzheimer's Dis</source>. <year>2017</year>;<volume>59</volume>(<issue>1</issue>):<fpage>169</fpage>‐<lpage>187</lpage>.<pub-id pub-id-type="pmid">28598839</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0032">
        <label>32</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0032">
<string-name>
<surname>Dillen</surname>
<given-names>KNH</given-names>
</string-name>, <string-name>
<surname>Jacobs</surname>
<given-names>HIL</given-names>
</string-name>, <string-name>
<surname>Kukolja</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Aberrant functional connectivity differentiates retrosplenial cortex from posterior cingulate cortex in prodromal Alzheimer's disease</article-title>. <source>Neurobiol Aging</source>. <year>2016</year>;<volume>44</volume>:<fpage>114</fpage>‐<lpage>126</lpage>.<pub-id pub-id-type="pmid">27318139</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0033">
        <label>33</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0033">
<string-name>
<surname>Celebi</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Uzdogan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Oguz</surname>
<given-names>KK</given-names>
</string-name>, et al. <article-title>Default mode network connectivity is linked to cognitive functioning and CSF Abeta1‐42 levels in Alzheimer's disease</article-title>. <source>Archiv Gerontol Geriatr</source>. <year>2016</year>;<volume>62</volume>:<fpage>125</fpage>‐<lpage>132</lpage>.</mixed-citation>
      </ref>
      <ref id="cns13716-bib-0034">
        <label>34</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0034">
<string-name>
<surname>Ye</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>An inverse U‐shaped curve of resting‐state networks in individuals at high risk of Alzheimer's disease</article-title>. <source>J Clin Psychiatry</source>. <year>2018</year>;<volume>79</volume>(<issue>2</issue>):<fpage>17m11583</fpage>.</mixed-citation>
      </ref>
      <ref id="cns13716-bib-0035">
        <label>35</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0035">
<string-name>
<surname>Stern</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Moeller</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>KE</given-names>
</string-name>, et al. <article-title>Different brain networks mediate task performance in normal aging and AD: defining compensation</article-title>. <source>Neurology</source>. <year>2000</year>;<volume>55</volume>(<issue>9</issue>):<fpage>1291</fpage>‐<lpage>1297</lpage>.<pub-id pub-id-type="pmid">11087770</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0036">
        <label>36</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0036">
<string-name>
<surname>Qi</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Impairment and compensation coexist in amnestic MCI default mode network</article-title>. <source>NeuroImage</source>. <year>2010</year>;<volume>50</volume>(<issue>1</issue>):<fpage>48</fpage>‐<lpage>55</lpage>.<pub-id pub-id-type="pmid">20006713</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0037">
        <label>37</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0037">
<string-name>
<surname>Yokoi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yamaguchi</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Involvement of the precuneus/posterior cingulate cortex is significant for the development of Alzheimer's disease: a PET (THK5351, PiB) and resting fMRI study</article-title>. <source>Front Aging Neurosci</source>. <year>2018</year>;<volume>10</volume>:<fpage>304</fpage>.<pub-id pub-id-type="pmid">30344488</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0038">
        <label>38</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0038">
<string-name>
<surname>Yu</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Mao</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Directed functional connectivity of posterior cingulate cortex and whole brain in Alzheimer's disease and mild cognitive impairment</article-title>. <source>Curr Alzheimer Res</source>. <year>2017</year>;<volume>14</volume>(<issue>6</issue>):<fpage>628</fpage>‐<lpage>635</lpage>.<pub-id pub-id-type="pmid">27915993</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0039">
        <label>39</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0039">
<string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Disrupted causal connectivity anchored in the posterior cingulate cortex in amnestic mild cognitive impairment</article-title>. <source>Front Neurol</source>. <year>2017</year>;<volume>8</volume>:<fpage>10</fpage>.<pub-id pub-id-type="pmid">28167926</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0040">
        <label>40</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0040">
<string-name>
<surname>Bai</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Watson</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Abnormal resting‐state functional connectivity of posterior cingulate cortex in amnestic type mild cognitive impairment</article-title>. <source>Brain Res</source>. <year>2009</year>;<volume>1302</volume>:<fpage>167</fpage>‐<lpage>174</lpage>.<pub-id pub-id-type="pmid">19765560</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0041">
        <label>41</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0041">
<string-name>
<surname>Moreno‐Grau</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ruiz</surname>
<given-names>A</given-names>
</string-name>. <article-title>Genome research in pre‐dementia stages of Alzheimer's disease</article-title>. <source>Exp Rev Mol Med</source>. <year>2016</year>;<volume>18</volume>:<fpage>e11</fpage>.</mixed-citation>
      </ref>
      <ref id="cns13716-bib-0042">
        <label>42</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0042">
<string-name>
<surname>Obler</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Rykhlevskaia</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schnyer</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Bilateral brain regions associated with naming in older adults</article-title>. <source>Brain Lang</source>. <year>2010</year>;<volume>113</volume>(<issue>3</issue>):<fpage>113</fpage>‐<lpage>123</lpage>.<pub-id pub-id-type="pmid">20399492</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0043">
        <label>43</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0043">
<string-name>
<surname>Saeed</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Mirza</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>MacIntosh</surname>
<given-names>BJ</given-names>
</string-name>, et al. <article-title>APOE‐ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies</article-title>. <source>Alzheimers Dement</source>. <year>2018</year>;<volume>14</volume>(<issue>9</issue>):<fpage>1137</fpage>‐<lpage>1147</lpage>.<pub-id pub-id-type="pmid">29782824</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0044">
        <label>44</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0044">
<string-name>
<surname>Savini</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pardini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Castellazzi</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Default mode network structural integrity and cerebellar connectivity predict information processing speed deficit in multiple sclerosis</article-title>. <source>Front Cell Neurosci</source>. <year>2019</year>;<volume>13</volume>:<fpage>21</fpage>.<pub-id pub-id-type="pmid">30853896</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0045">
        <label>45</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0045">
<string-name>
<surname>Ruffle</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Giampietro</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Functional brain networks and neuroanatomy underpinning nausea severity can predict nausea susceptibility using machine learning</article-title>. <source>J Physiol</source>. <year>2019</year>;<volume>597</volume>(<issue>6</issue>):<fpage>1517</fpage>‐<lpage>1529</lpage>.<pub-id pub-id-type="pmid">30629751</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0046">
        <label>46</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0046">
<string-name>
<surname>Espinoza</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ciarochi</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Dynamic functional network connectivity in Huntington's disease and its associations with motor and cognitive measures</article-title>. <source>Hum Brain Mapp</source>. <year>2019</year>;<volume>40</volume>(<issue>6</issue>):<fpage>1955</fpage>‐<lpage>1968</lpage>.<pub-id pub-id-type="pmid">30618191</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0047">
        <label>47</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0047">
<string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ward</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Classification of Alzheimer disease, mild cognitive impairment, and normal cognitive status with large‐scale network analysis based on resting‐state functional MR imaging</article-title>. <source>Radiology</source>. <year>2011</year>;<volume>259</volume>(<issue>1</issue>):<fpage>213</fpage>‐<lpage>221</lpage>.<pub-id pub-id-type="pmid">21248238</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0048">
        <label>48</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0048">
<string-name>
<surname>Gu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Abnormal dynamic functional connectivity in Alzheimer's disease</article-title>. <source>CNS Neurosci Ther</source>. <year>2020</year>;<volume>26</volume>(<issue>9</issue>):<fpage>962</fpage>‐<lpage>971</lpage>.<pub-id pub-id-type="pmid">32378335</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0049">
        <label>49</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0049">
<string-name>
<surname>Ramanathan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nelson</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Sagare</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Zlokovic</surname>
<given-names>BV</given-names>
</string-name>. <article-title>Impaired vascular‐mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1</article-title>. <source>Front Aging Neurosci</source>. <year>2015</year>;<volume>7</volume>:<fpage>136</fpage>.<pub-id pub-id-type="pmid">26236233</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0050">
        <label>50</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0050">
<string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bander</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Muoser</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schaffer</surname>
<given-names>CB</given-names>
</string-name>, <string-name>
<surname>Nishimura</surname>
<given-names>N</given-names>
</string-name>. <article-title>Microvessel occlusions alter amyloid‐beta plaque morphology in a mouse model of Alzheimer's disease</article-title>. <source>J Cerebral Blood Flow Metab</source>. <year>2020</year>;<volume>40</volume>(<issue>10</issue>):<fpage>2115</fpage>‐<lpage>2131</lpage>.</mixed-citation>
      </ref>
      <ref id="cns13716-bib-0051">
        <label>51</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0051">
<string-name>
<surname>Liu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ahmet</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Griess</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tweedie</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Greig</surname>
<given-names>NH</given-names>
</string-name>, <string-name>
<surname>Mattson</surname>
<given-names>MP</given-names>
</string-name>. <article-title>Age‐related impairment of cerebral blood flow response to K(ATP) channel opener in Alzheimer's disease mice with presenilin‐1 mutation</article-title>. <source>J Cerebral Blood Flow Metab</source>. <year>2021</year>;<volume>41</volume>(<issue>7</issue>):<fpage>1579</fpage>‐<lpage>1591</lpage>.</mixed-citation>
      </ref>
      <ref id="cns13716-bib-0052">
        <label>52</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0052">
<string-name>
<surname>Dounavi</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Low</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>McKiernan</surname>
<given-names>EF</given-names>
</string-name>. <article-title>Evidence of cerebral hemodynamic dysregulation in middle‐aged APOE ε4 carriers: The PREVENT‐Dementia study</article-title>. <source>J Cerebral Blood Flow Metab</source>. <year>2021</year>. <pub-id pub-id-type="doi">10.1177/0271678x211020863</pub-id>. Online ahead of print.</mixed-citation>
      </ref>
      <ref id="cns13716-bib-0053">
        <label>53</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0053">
<string-name>
<surname>Kaufman</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Honea</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Pleen</surname>
<given-names>J</given-names>
</string-name> et al. <article-title>Aerobic exercise improves hippocampal blood flow for hypertensive Apolipoprotein E4 carriers</article-title>. <source>J Cerebral Blood Flow Metab</source>. <year>2021</year>.<volume>41</volume>(<issue>8</issue>):<fpage>2026</fpage>–<lpage>2037</lpage>.</mixed-citation>
      </ref>
      <ref id="cns13716-bib-0054">
        <label>54</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0054">
<string-name>
<surname>Kuang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Tian</surname>
<given-names>HZ</given-names>
</string-name>, et al. <article-title>Exploring the bi‐directional relationship between autophagy and Alzheimer's disease</article-title>. <source>CNS Neurosci Ther</source>. <year>2020</year>;<volume>26</volume>(<issue>2</issue>):<fpage>155</fpage>‐<lpage>166</lpage>.<pub-id pub-id-type="pmid">31503421</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0055">
        <label>55</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0055">
<string-name>
<surname>Cho</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Gonzales‐Portillo</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Gut dysbiosis in stroke and its implications on Alzheimer's disease‐like cognitive dysfunction</article-title>. <source>CNS Neurosci Ther</source>. <year>2021</year>;<volume>27</volume>(<issue>5</issue>):<fpage>505</fpage>‐<lpage>514</lpage>.<pub-id pub-id-type="pmid">33464726</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0056">
        <label>56</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0056">
<string-name>
<surname>Cramer</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Cirrito</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Wesson</surname>
<given-names>DW</given-names>
</string-name>, et al. <article-title>ApoE‐directed therapeutics rapidly clear beta‐amyloid and reverse deficits in AD mouse models</article-title>. <source>Science</source>. <year>2012</year>;<volume>335</volume>(<issue>6075</issue>):<fpage>1503</fpage>‐<lpage>1506</lpage>.<pub-id pub-id-type="pmid">22323736</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0057">
        <label>57</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0057">
<string-name>
<surname>Mulder</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Nielsen</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Blankenstein</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Eikelenboom</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Veerhuis</surname>
<given-names>R</given-names>
</string-name>. <article-title>Apolipoproteins E and J interfere with amyloid‐beta uptake by primary human astrocytes and microglia in vitro</article-title>. <source>Glia</source>. <year>2014</year>;<volume>62</volume>(<issue>4</issue>):<fpage>493</fpage>‐<lpage>503</lpage>.<pub-id pub-id-type="pmid">24446231</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0058">
        <label>58</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0058">
<string-name>
<surname>Cascella</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Conti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tatini</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Extracellular chaperones prevent Abeta42‐induced toxicity in rat brains</article-title>. <source>Biochem Biophys Acta</source>. <year>2013</year>;<volume>1832</volume>(<issue>8</issue>):<fpage>1217</fpage>‐<lpage>1226</lpage>.<pub-id pub-id-type="pmid">23602994</pub-id></mixed-citation>
      </ref>
      <ref id="cns13716-bib-0059">
        <label>59</label>
        <mixed-citation publication-type="journal" id="cns13716-cit-0059">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cella</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mallinson</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model</article-title>. <source>Cell</source>. <year>2015</year>;<volume>160</volume>(<issue>6</issue>):<fpage>1061</fpage>‐<lpage>1071</lpage>.<pub-id pub-id-type="pmid">25728668</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
